Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Resilient Biotics, a US-based developer of microbiome-based treatments for respiratory infections in animals, has raised $7.1m in a series A round co-led by Berkeley Catalyst Fund, a venture unit aligned to University of California (UC) Berkeley, according to AgFunderNews. Fulcrum Global Capital co-led the round, which also included veterinary medicine producer Elanco Animal Health as…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.